Philips Healthcare is differentiating its PACS at RSNA 2008 by offering a wide variety of ancillary and complementary functions developed by other vendors but presented by Philips as optional software packages geared to work with its iSite system.
Philips Healthcare is differentiating its PACS at RSNA 2008 by offering a wide variety of ancillary and complementary functions developed by other vendors but presented by Philips as optional software packages geared to work with its iSite system.
The company is framing the strategy as spawning an IT-based "ecosystem" composed of about a dozen suppliers of software products. Customers can pick and choose from an array of possibilities. One is Amirsys' STATdx Diagnostic Decision Support System, which offers reference tools useful in the diagnostic process. Another is a suite of communications tools from Primordial, including an integrated instant messaging and e-mail program that keeps radiologists in contact with other providers.
The strategy provides Philips' customers and prospects an expanding set of capabilities with minimal in-house effort, thereby conserving the company's engineering resources to develop clinical applications. These include 3D visualization tools such as iSite Volume Vision, Pulmonary Embolism Assessment, and the work-in-progress CT Colonography product. The idea grew from the observation that an increasing number of vendors are going directly to customers, a trend that became apparent when Philips was called in to help integrate iSite with various software packages. Over time, the company has developed tight integrations and good relationships with these firms. This sparked the idea of expanding Philips' portfolio by offering choices developed by these companies.
STATdx is a logical complement to iSite. As the world's largest radiology reference database of diagnoses and images, the software helps radiologists form diagnoses faster, more accurately, and with greater confidence. With this and other add-ons to iSite, Philips seeks to empower its customers -- and itself.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.